NO924780L - Ekspresjon av spesifikke immunogener ved bruk av virusantigener - Google Patents

Ekspresjon av spesifikke immunogener ved bruk av virusantigener

Info

Publication number
NO924780L
NO924780L NO92924780A NO924780A NO924780L NO 924780 L NO924780 L NO 924780L NO 92924780 A NO92924780 A NO 92924780A NO 924780 A NO924780 A NO 924780A NO 924780 L NO924780 L NO 924780L
Authority
NO
Norway
Prior art keywords
nucleotide sequence
peptides
antigens
expression
encoding
Prior art date
Application number
NO92924780A
Other languages
English (en)
Other versions
NO924780D0 (no
Inventor
Paul Porwen Hung
Shaw-Guang Lin Lee
Narender Kumar Kalyan
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO924780D0 publication Critical patent/NO924780D0/no
Publication of NO924780L publication Critical patent/NO924780L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Det er tilveiebrakt kimæriske DNA-fragmenter som innbe- fatter en nukleotidsekvens som hovedsakelig er den samme som den som koder for HA-overflateproteinet av et influensa A- virus med fem immundominante antigenseter, hvor en nukleotid- sekvens som hovedsakelig er den samme som den som koder for en fremmed epitop, innføres i nukleotidsekvensen i et antigen- sted. Tilsvarende kimæriske peptider, ekspresjpnsvektorer og transformerte verter er også tilveiebrakt. Disse peptider er egnet for tilveiebringelse av vaksiner mot de respektive antigener og i forsøkssett for påvisning av individers utset- telse for slike antigener. Dessuten er disse peptider eller deres tilsvarende antistoffer egnet ved metoder for behandling og forebygging av utslagene av utsettelse for disse antigener, innbefattende immunterapi.
NO92924780A 1991-12-11 1992-12-10 Ekspresjon av spesifikke immunogener ved bruk av virusantigener NO924780L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80510591A 1991-12-11 1991-12-11

Publications (2)

Publication Number Publication Date
NO924780D0 NO924780D0 (no) 1992-12-10
NO924780L true NO924780L (no) 1993-06-14

Family

ID=25190685

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924780A NO924780L (no) 1991-12-11 1992-12-10 Ekspresjon av spesifikke immunogener ved bruk av virusantigener

Country Status (17)

Country Link
US (1) US5591823A (no)
EP (1) EP0546787A3 (no)
JP (1) JPH05262667A (no)
KR (1) KR930013112A (no)
CN (1) CN1073878A (no)
AU (1) AU2981992A (no)
BR (1) BR9204978A (no)
CA (1) CA2084180A1 (no)
CZ (1) CZ362692A3 (no)
FI (1) FI925590A (no)
HU (2) HUT65366A (no)
IL (1) IL103928A0 (no)
MX (1) MX9207113A (no)
NO (1) NO924780L (no)
SK (1) SK362692A3 (no)
TW (1) TW239162B (no)
ZA (1) ZA929355B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3649335B2 (ja) * 1992-04-01 2005-05-18 ザ ロックフェラー ユニバーシティー 樹枝状細胞前駆体のインビトロ増殖の方法およびその免疫原製造への使用
EP0671926B1 (en) * 1992-08-11 2002-11-13 President And Fellows Of Harvard College Immunomodulatory peptides
WO1995007099A1 (fr) * 1993-09-09 1995-03-16 The Nisshin Oil Mills, Ltd. Vaccin et procede pour sa production
ES2370937T3 (es) 1993-09-13 2011-12-23 Protein Sciences Corporation Un método para producir vacunas antigripales polivalentes a base de hemaglutinina.
EP2374894B1 (en) * 1993-09-13 2014-09-17 Protein Sciences Corporation A method for producing influenza hemagglutinin multivalent vaccines
US5762939A (en) * 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
US6300090B1 (en) 1994-07-29 2001-10-09 The Rockefeller University Methods of use of viral vectors to deliver antigen to dendritic cells
DE69535716T2 (de) * 1995-05-26 2009-03-19 Protein Sciences Corp., Meriden Methode für die Produktion von multivalenten Influenza Hämagglutinin Vakzinen
US7659119B2 (en) 1996-02-12 2010-02-09 Argos Therapeutics, Inc. Method and compositions for obtaining mature dendritic cells
AU7471098A (en) * 1997-04-30 1998-11-24 Mount Sinai School Of Medicine Of The City University Of New York, The Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents
DE69840739D1 (de) 1997-10-27 2009-05-28 Merix Bioscience Inc Methode und Zusammensetzung zur Herstellung von reifen dendritischen Zellen
AU2872199A (en) 1998-02-20 1999-09-06 Rockefeller University, The Apoptotic cell-mediated antigen presentation to dendritic cells
WO2002026252A1 (fr) * 2000-08-10 2002-04-04 Tsinghua University Vaccin contre le virus de la grippe et son procede de preparation
US20020157752A1 (en) 2000-09-11 2002-10-31 The Dow Chemical Company Run flat tire support and reinforcement member therefor
US20040203084A1 (en) * 2003-04-10 2004-10-14 Doug Levinson Profiling conformational variants, antibody compositions and methods of using the same
JP4939531B2 (ja) * 2005-06-01 2012-05-30 ヴァリエーション バイオテクノロジーズ インコーポレイテッド ペプチドベースのインフルエンザワクチン製剤
CA2637600A1 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
TWI610939B (zh) * 2007-02-21 2018-01-11 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
EP2012122A1 (en) * 2007-07-06 2009-01-07 Medigene AG Mutated parvovirus structural proteins as vaccines
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
EP2772267B1 (en) * 2007-08-27 2016-04-27 Longhorn Vaccines and Diagnostics, LLC Immunogenic compositions and methods
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
RU2532105C2 (ru) 2008-10-22 2014-10-27 Онкотерапи Сайенс, Инк. Эпитопные пептиды rab6kifl/kif20a и содержащие их вакцины
CN101708442B (zh) * 2009-09-04 2011-08-24 山东中惠仪器有限公司 全自动标准气体配制装置
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10063211B2 (en) * 2016-02-03 2018-08-28 Qualcomm Incorporated Compact bypass and decoupling structure for millimeter-wave circuits
CN114634916A (zh) 2016-02-03 2022-06-17 Cg探索股份有限公司 具有异源表位和/或改变的成熟切割位点的流感血凝素的组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
EP0492920A1 (en) * 1990-12-24 1992-07-01 Merck & Co. Inc. Chimaeric influenza-HIV vaccine

Also Published As

Publication number Publication date
JPH05262667A (ja) 1993-10-12
US5591823A (en) 1997-01-07
BR9204978A (pt) 1993-06-15
HUT65366A (en) 1994-05-02
TW239162B (no) 1995-01-21
MX9207113A (es) 1994-05-31
HU9203931D0 (en) 1993-04-28
HU211548A9 (en) 1995-12-28
IL103928A0 (en) 1993-04-04
KR930013112A (ko) 1993-07-21
ZA929355B (en) 1994-06-02
FI925590A (fi) 1993-06-12
FI925590A0 (fi) 1992-12-09
CA2084180A1 (en) 1993-06-12
EP0546787A2 (en) 1993-06-16
SK362692A3 (en) 1995-11-08
CN1073878A (zh) 1993-07-07
AU2981992A (en) 1993-06-17
CZ362692A3 (en) 1994-02-16
EP0546787A3 (en) 1994-06-01
NO924780D0 (no) 1992-12-10

Similar Documents

Publication Publication Date Title
NO924780L (no) Ekspresjon av spesifikke immunogener ved bruk av virusantigener
Reagan et al. Anti-idiotypic antibodies induce neutralizing antibodies to rabies virus glycoprotein
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
BR0207067A (pt) Método para identificar, isolar e produzir antìgenos para um patógeno especìfico e uso do mesmo
SE8701413D0 (sv) Expression and purification of an htlv-iii gag/env gene protein
DE69533912D1 (de) Antikörper gegen Epitope mit Homologie zu Auto-Antigenen, Verfahren zur Herstellung und deren Verwendungen
BR9406595A (pt) Processo para a preparação dos imunógenos ou reagentes para diagnóstico que mimetizam um antigeno ou um organismo patogênico especifico para uma doença fagos vacinas contra um agente patogênico especifico e plasmideos pc89 modificados
Lawson et al. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis.
NO963508L (no) Urease-basert vaksine og behandling av Helicobacter-infeksjon
WO1995029193A3 (en) Melanoma antigens
SE8604007L (sv) Vaccin och immunoanalyser for forvervat immunbristsyndrom (aids)
NO962426L (no) Spermieantigen som tilsvarer et spermie zonabindende protein autoantigenepitop
HUP9903770A2 (hu) Eljárások és készítmények többepitópos antigének konformációjának megváltoztatására immunválasz kiváltása céljából
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
NO954318D0 (no) Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener
MX9801089A (es) Proteina hibrida que comprende epitopes estimulantes de celula auxiliar t y epitopes de celula b de la proteina de membrana externa mayor chlamydia trachomatis y su uso como vacuna.
ATE382696T1 (de) Immunoreaktive antigene des hepatitis e viruses
DE68923286D1 (de) Impfstoffe und testsätze für haemophilus influenzae.
ATE189683T1 (de) Hcv peptidantigene und verfahren zur bestimmung von hcv
WO1996012190A3 (en) Presentation of hydrophobic antigens to t-cells by cd1 molecules
WO2004052930A3 (en) Targeting single epitopes
Parry et al. A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles.
EP0370090B1 (en) Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens
BR9905780A (pt) Antìgenos vacinais de leptospira para prevenção da laptospirose
DE60025522D1 (de) Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung